Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors.

Saved in:
Bibliographic Details
Title: Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors.
Authors: Konig, H.1, Holtz, M.1, Modi, H.1, Manley, P.2, Holyoake, T. L.3, Forman, S. J.1, Bhatia, R.1 rbhatia@coh.org
Source: Leukemia (08876924). Apr2008, Vol. 22 Issue 4, p748-755. 8p. 2 Black and White Photographs, 2 Graphs.
Database: Academic Search Ultimate
Description
ISSN:08876924
DOI:10.1038/sj.leu.2405086